Section effective Oct. 1, 1992, with provision for programs providing financial assistance, see section 801(c), (d) of Puspan. L. 102–321, set out as an Effective Date of 1992 Amendment note under section 236 of this title.

Section 706 of Puspan. L. 102–321 directed Secretary of Health and Human Services to contract for a study or studies relating to programs that provide both sterile hypodermic needles and bleach to individuals in order to reduce the risk of contracting acquired immune deficiency syndrome or related conditions, in order to determine extent to which such programs promote the abuse of drugs or otherwise altered any behaviors constituting a substantial risk of contracting AIDS or hepatitus, or of transmitting such conditions, and further directed Secretary to ensure that a report is submitted to Congress on the results of this study not later than 18 months after July 10, 1992.